
The Amir Chand Jagadish Kumar Exports IPO enters its second day of subscription today, 25 March 2026. By the end of the first day, the issue was subscribed to 1.26 times overall. The bidding window is scheduled to close on March 27, 2026.
Issue Type: The Amir Chand Jagadish Kumar Exports IPO is a ₹440 crore book-building issue, consisting entirely of a fresh issue of 2.08 crore shares.
Price Band: The price band is set between ₹201 and ₹212 per share.
Lot Size & Minimum Investment: The lot size for an application is 46 shares, and the minimum investment required is ₹14,840 (for retail investors).
Allotment Date: The basis of allotment will be finalised by March 30, 2026
Listing Date: The tentative listing date on NSE and BSE is April 2, 2026.
Book-running Lead Managers: Emkay Global Financial Services Limited and Keynote Financial Services Limited
Registrar: KFin Technologies Limited
[25-March-2026 11:18:00 hrs]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
0.58 |
|
Non-Institutional Investors |
4.82 |
|
Retail Individual Investors (RIIs) |
0.46 |
|
Total |
1.27 |
The net proceeds from the fresh issue will be used to fund the expenses towards the following objectives:
Explore other Upcoming IPOs on BSE and NSE.
According to media reports, the Grey Market Premium (GMP) for the Amir Chand Jagadish Kumar Exports IPO is ₹7 over the IPO price.
Amir Chand Jagadish Kumar Exports is engaged in the processing and export of basmati rice along with a portfolio of FMCG products. According to an independent industry report commissioned by the company, it ranked 3rd among the leading players in the Indian rice industry by revenue.
Their product offerings are broadly divided into two segments: (i) rice and (ii) FMCG products. The rice segment includes basmati rice as well as other varieties such as sona masuri, kolam, ponni, and idli rice. The products are marketed under the flagship brand "AEROPLANE."
Check out newly Listed IPOs on BSE and NSE.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.